Abstract
Estimates from the UK indicate that around 0.5–1.0% of the population have rheumatoid arthritis.1 Here we assess the place of rituximab (MabThera – Roche Products Ltd) and ▼abatacept (Orencia –...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have